Bdx stock price forecast institutional sentiment for the BDX

Institutional sentiment for the BDX stock price forecast is solid, as 70% of shares are held by long-term funds. Dividend consistency reinforces investor confidence, translating into reduced downside risk. Stay updated when valuation signals shift by adding Becton Dickinson to your watchlist or portfolio . Alternatively, explore our screener to discover other companies that fit your criteria. In addition to the financial measures presented in accordance with U.S. generally accepted accounting principles (" U.S. GAAP "), this communication includes certain non-GAAP financial measures (collectively, the " Non-GAAP Measures "), such as adjusted EBITDA, adjusted EPS and adjusted operating margin. These Non-GAAP Measures should not be used in isolation or as a substitute or alternative to results determined in accordance with U.S. GAAP. In addition, Waters' and BD's definitions of these Non-GAAP Measures may not be comparable to similarly titled non-GAAP financial measures reported by other companies. For Calendar Year 2025, Waters' projected adjusted EBITDA for BD's Biosciences & Diagnostic Solutions business is approximately $925 million. Due to the SEC methodology that requires allocating BD's corporate overhead costs (approximately $200 million), which are not required to operate the Bioscience & Diagnostic Solutions business and will not transfer post-spin, as well as approximately $100 million in one-time, non-recurring costs related to the spin-off, transaction, and restructuring, EBITDA for BD's Biosciences & Diagnostic Solutions business in BD's carveout financial statements for the same period would be expected to be approximately $300 million lower. If volume increases above average, traders may target the next resistance near $